All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry

Y06137

CAS number:2226534-49-0    molecular formula:C27H32N4O2

overview

compound introduction

Y06137 is a potent and selective BET inhibitor for treatment of castration-resistant prostate cancer (CRPC). Y06137 binds to the BRD4(1) bromodomain with a K d of 81 nM In Vitro Y06137 (0.001-100 nM, 96 hours for LNCaP, C4-2B, and 22Rv1 cells; 144 hours for VCaP cells) exhibits low micromolar or nanomolar potencies (IC 50 : 0.29-2.6 μΜ) in the four androgen receptor (AR)-positive prostate cancer cell lines LNCaP, C4-2B, 22Rv1, and VCaP. Treatment of 22Rv1 cells with Y06137 (1, 2, 4, 8, and 16 μM, 48 hours) results in significant down-regulation of both full-length (AR-fl) and AR variants levels. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: AR-positive prostate cancer cell lines LNCaP, C4-2B, 22Rv1, and VCaP Concentration: 0.001-100 μM Incubation Time: 96 hours for LNCaP, C4-2B, and 22Rv1; 144 hours for VCaP Result: Inhibited LNCaP, C4-2B, 22Rv1, and VCaP cells with IC 50 s of 0.47, 0.84, 0.70, 0.29 μM, respectively. Western Blot AnalysisCell Line: AR-positive prostate cancer cell lines 22Rv1 Concentration: 1, 2, 4, 8, and 16 μM Incubation Time: 48 hours Result: Resulted in significant down-regulation of both AR-fl and AR variants levels. In Vivo Y06137 (50 mg/kg, i.p. injection, 5 times per week, 25 days) demonstrates therapeutic effects in a C4-2B CRPC xenograft tumor model in mice. Y06137 is well tolerated in the treated mice, based on the weight of the animal body and their general behavior . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Four-week-old male mice (strain: C.B-17/IcrHsd- Prkdc scid for C4-2B) with C4-2B mouse xenograft model Dosage: 50 mg/kg, 100 μL Administration: Intraperitoneal (i.p.) injection, 5 times per week, 25 days Result: Exhibited strong antitumor activities during the 25-day treatment period, with a tumor growth inhibition (TGI) of 51%. Form:Solid IC50& Target:BRD4(1) 81 nM (Kd)

Specs

Chinese alias-
English alias-
CAS number2226534-49-0molecular formulaC27H32N4O2
molecular weight444.57 g/molExact mass≥99%
PSA-logp-

numbering system

No numbering system information yet

physicochemical properties

No physical and chemical property information yet

Safety information

No safety information yet

Production methods and uses

No production method and use information yet

Related

upstream information

No upstream information yet

downstream information

No downstream information yet

MSDS

Found 0 shareMSDS